Captor Therapeutics SA (60Q) Stock Price & News

All values in PLN	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	44.00K	328.00K	1.63M
Cost of goods sold	-2.02M	-	-	173.00K
Cost of revenue	-2.02M	-	-	173.00K
Research and development expenses	14.74M	9.82M	10.56M	13.78M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.37M	2.53M	1.92M	2.25M
Operating expense	13.83M	10.40M	11.59M	14.39M
Total operating expenses	11.81M	10.40M	11.59M	14.56M
Operating income	-11.81M	-10.36M	-11.26M	-12.93M
Other non operating income	1.00K	-8.00K	-	-
EBT including unusual items	-11.48M	-10.05M	-11.35M	-11.39M
EBT excluding unusual items	-11.48M	-10.12M	-11.35M	-11.39M
Income tax expense	-	-	27.00K	-
Effective tax rate	-	-	-0.24%	-
Other operating expenses	-2.27M	-1.94M	-893.00K	-1.64M
Net income	-11.48M	-10.05M	-11.38M	-11.39M
Net profit margin	-	-22,831.82%	-3,467.99%	-696.88%
Earnings per share	-	-	-	-
Interest and investment income	391.00K	303.00K	39.00K	1.63M
Interest expense	-61.00K	-75.00K	-67.00K	-57.00K
Net interest expenses	330.00K	228.00K	-28.00K	1.57M
Depreciation and amortization charges	-	-	-	-
EBITDA	-10.81M	-9.53M	-10.36M	-12.04M
Gain or loss from assets sale	-682.00K	-	-	-128.00K

Finance